ProfileGDS4718 / 232811_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 32% 34% 41% 37% 33% 32% 33% 38% 39% 35% 37% 41% 35% 33% 37% 36% 42% 29% 33% 34% 35% 35% 34% 38% 32% 31% 34% 35% 34% 37% 39% 33% 37% 36% 37% 34% 30% 35% 37% 42% 35% 33% 36% 35% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.6371432
GSM549102patient 115, normal, homogenized [OPG study]4.7095834
GSM549104patient 119, normal, homogenized [OPG study]5.0143441
GSM549108patient 138, normal, homogenized [OPG study]4.9202237
GSM549119patient 077, normal, homogenized [OPG study]4.7002833
GSM549133patient 032, cancer, homogenized [OPG study]4.583532
GSM549139patient 042, cancer, homogenized [OPG study]4.6586733
GSM549099patient 107, normal, homogenized [OPG study]4.8975438
GSM549109patient 139, normal, homogenized [OPG study]4.9756739
GSM549110patient 046, normal, homogenized [OPG study]4.7565335
GSM549114patient 063, normal, homogenized [OPG study]4.8154637
GSM549122patient 082, normal, homogenized [OPG study]5.0309541
GSM549134patient 033, cancer, homogenized [OPG study]4.7533235
GSM549136patient 036, cancer, homogenized [OPG study]4.6258833
GSM549140patient 044, cancer, homogenized [OPG study]4.8249137
GSM549111patient 047, normal, homogenized [OPG study]4.7943736
GSM549113patient 057, normal, homogenized [OPG study]5.011242
GSM549132patient 031, cancer, homogenized [OPG study]4.4983429
GSM549137patient 038, cancer, homogenized [OPG study]4.6684133
GSM549142patient 047, cancer, homogenized [OPG study]4.8488434
GSM549100patient 110, normal, homogenized [OPG study]4.7775935
GSM549107patient 135, normal, homogenized [OPG study]4.7260435
GSM549115patient 068, normal, homogenized [OPG study]4.6630734
GSM549116patient 072, normal, homogenized [OPG study]4.8542638
GSM549120patient 078, normal, homogenized [OPG study]4.6080932
GSM549131patient 030, cancer, homogenized [OPG study]4.5427531
GSM549118patient 074, normal, homogenized [OPG study]4.716434
GSM549129patient 027, cancer, homogenized [OPG study]4.7595135
GSM549123patient 088, normal, homogenized [OPG study]4.6949934
GSM549124patient 006, cancer, homogenized [OPG study]4.9058537
GSM549126patient 015, cancer, homogenized [OPG study]4.9187339
GSM549128patient 025, cancer, homogenized [OPG study]4.6515333
GSM549103patient 117, normal, homogenized [OPG study]4.9329737
GSM549117patient 073, normal, homogenized [OPG study]4.7697636
GSM549138patient 041, cancer, homogenized [OPG study]4.8490337
GSM549141patient 045, cancer, homogenized [OPG study]4.6609734
GSM549130patient 028, cancer, homogenized [OPG study]4.5518430
GSM549101patient 111, normal, homogenized [OPG study]4.798235
GSM549105patient 128, normal, homogenized [OPG study]4.8633237
GSM549106patient 134, normal, homogenized [OPG study]5.0271242
GSM549112patient 048, normal, homogenized [OPG study]4.7703735
GSM549125patient 011, cancer, homogenized [OPG study]4.6806433
GSM549127patient 024, cancer, homogenized [OPG study]4.79136
GSM549135patient 035, cancer, homogenized [OPG study]4.6961335